These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Paroxetine: a pharmacological review. Johnson AM Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():15-24. PubMed ID: 1331230 [TBL] [Abstract][Full Text] [Related]
23. Expanding psychopharmacologic treatment options for the depressed medical patient. Stoudemire A Psychosomatics; 1995; 36(2):S19-26. PubMed ID: 7724709 [TBL] [Abstract][Full Text] [Related]
24. The medical consequences of the selection of an antidepressant. Nierenberg AA J Clin Psychiatry; 1992 Sep; 53 Suppl():19-24. PubMed ID: 1522076 [TBL] [Abstract][Full Text] [Related]
25. First results of an open phase II study with the antidepressant paroxetine. Stuppäck C; Schubert H; Barnas C; Mair M; Schifferle I; Unterweger B; Wömhart L; Fleischhacker WW; Hinterhuber H Pharmacopsychiatry; 1988 Nov; 21(6):369-70. PubMed ID: 2977442 [No Abstract] [Full Text] [Related]
26. A comparison of paroxetine, imipramine and placebo in depressed out-patients. Dunbar GC; Cohn JB; Fabre LF; Feighner JP; Fieve RR; Mendels J; Shrivastava RK Br J Psychiatry; 1991 Sep; 159():394-8. PubMed ID: 1835664 [TBL] [Abstract][Full Text] [Related]
28. Cardiovascular effects of antidepressants: studies of paroxetine in healthy men and depressed patients. Warrington SJ; Lewis Y Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():59-64. PubMed ID: 1431013 [TBL] [Abstract][Full Text] [Related]
29. No crossover reactions to citalopram or paroxetine among patients hypersensitive to zimeldine. Bengtsson BO; Lundmark J; Wålinder J Br J Psychiatry; 1991 Jun; 158():853-5. PubMed ID: 1831396 [TBL] [Abstract][Full Text] [Related]
30. A double-blind comparison of paroxetine and placebo in the treatment of depressed patients in a psychiatric outpatient clinic. Miller SM; Naylor GJ; Murtagh M; Winslow G Acta Psychiatr Scand Suppl; 1989; 350():143-4. PubMed ID: 2530772 [No Abstract] [Full Text] [Related]
31. A clinical profile of paroxetine: a novel selective serotonin reuptake inhibitor (SSRI). J Clin Psychiatry; 1992 Feb; 53 Suppl():1-68. PubMed ID: 1531815 [No Abstract] [Full Text] [Related]
32. Abrupt and brief discontinuation of antidepressant treatment: effects on cognitive function and psychomotor performance. Hindmarch I; Kimber S; Cockle SM Int Clin Psychopharmacol; 2000 Nov; 15(6):305-18. PubMed ID: 11110006 [TBL] [Abstract][Full Text] [Related]
33. Cardiovascular effects of paroxetine. Kuhs H; Rudolf GA Psychopharmacology (Berl); 1990; 102(3):379-82. PubMed ID: 2147517 [TBL] [Abstract][Full Text] [Related]
34. Paroxetine plasma levels: lack of correlation with efficacy or adverse events. Tasker TC; Kaye CM; Zussman BD; Link CG Acta Psychiatr Scand Suppl; 1989; 350():152-5. PubMed ID: 2530776 [No Abstract] [Full Text] [Related]
35. The effect of paroxetine on the electroencephalogram, electrocardiogram, and blood pressure. Edwards JG; Goldie A; Papayanni-Papasthatis S; Punter J; Sedgwick EM Acta Psychiatr Scand Suppl; 1989; 350():124. PubMed ID: 2530762 [No Abstract] [Full Text] [Related]